The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production.
about
Thrombopoietin as biomarker and mediator of cardiovascular damage in critical diseasesClinical indications for thrombopoietin and thrombopoietin-receptor agonistsThe Centenary of Immune Thrombocytopenia - Part 1: Revising Nomenclature and PathogenesisEltrombopag for the treatment of aplastic anemia: current perspectivesThe cell cycle in polyploid megakaryocytes is associated with reduced activity of cyclin B1-dependent cdc2 kinaseZinc finger protein, Hzf, is required for megakaryocyte development and hemostasisThrombopoietin.Plasma thrombopoietin levels in liver cirrhosis and kidney failure.Phase 1 study of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in breast cancer patients after autologous peripheral blood progenitor cell (PBPC) transplantation.Use of PEG-rHuMGDF in platelet engraftment after autologous stem cell transplantation.Human plasma thrombopoietin levels are regulated by binding to platelet thrombopoietin receptors in vivo.Thrombopoietin as a drug: biologic expectations, clinical realities, and future directions.Suspects in the tale of lupus-associated thrombocytopenia.Haematopoietic stem and progenitor cell-targeted therapies for thrombocytopenia.Historical review: megakaryopoiesis and thrombopoiesisThrombopoietin and platelet production in chronic immune thrombocytopenia.Biology and chemistry of thrombopoietic agentsEltrombopag--a novel approach for the treatment of chronic immune thrombocytopenic purpura: review and safety considerations.The development of romiplostim for patients with immune thrombocytopenia.ITP: a historical perspective.Thrombopoietin and hematopoietic stem cells.The efficacy and safety of romiplostim in adult patients with chronic immune thrombocytopenia.Immune thrombocytopenia -- what are the new treatment options?The biology of thrombopoietin and thrombopoietin receptor agonists.Exome sequencing reveals a thrombopoietin ligand mutation in a Micronesian family with autosomal recessive aplastic anemia.Eltrombopag for the treatment of thrombocytopenia in patients with malignant and non-malignant hematologic disorders.Interpreting the developmental dance of the megakaryocyte: a review of the cellular and molecular processes mediating platelet formation.Thrombopoietin from beginning to end.Milestones in understanding platelet production: a historical overview.The pharmacology and clinical application of thrombopoietin receptor agonists.Severe romiplostim-induced rebound thrombocytopenia after splenectomy for refractory ITP.Romiplostim as a treatment for immune thrombocytopenia: a review.Thrombopoiesis-stimulating agents and myelodysplastic syndromes.Eltrombopag for treatment of thrombocytopenia-associated disorders.Advances in the pathophysiology of primary immune thrombocytopenia.Lusutrombopag increases hematocytes in a compensated liver cirrhosis patientFrom chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag.Megakaryocyte growth and development factor. Analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopeniaPlasma thrombopoietin levels in thrombocytopenic states: implication for a regulatory role of bone marrow megakaryocytes.Clonality analysis of hematopoiesis and thrombopoietin levels in patients with essential thrombocythemia.
P2860
Q21296645-56577E19-16FF-4891-8A31-4756D40F6FAAQ24601161-355C484D-AF16-4128-8B9A-712218B95D9AQ28068881-1B9B6DA6-3A40-445A-BC09-19BEA2FA96B1Q28071710-D1A0CAB1-78DF-4D7F-AC35-348069780351Q28278405-A3DE2FEA-214F-4877-9264-49A188E9CE59Q28504828-2FF5E552-79B1-426B-AB92-74EDC6061C81Q33330090-9067A77D-A5E1-4E98-AD1B-1EAF9F2C559CQ33330805-8E51C81C-6420-49EA-A606-0695CD0FF97CQ33333334-06F31642-E852-4B58-80C7-869AB257443AQ33335364-35449AB8-308B-4F98-BC71-D90EC1FBB4ECQ33342032-4C8BA4A8-05F6-4C84-8188-08952E5DDFB8Q33344528-610EB466-B349-4AFA-8EB7-6EE85FE234ECQ33371650-A9CC689D-3062-4406-BF49-082F1F219082Q33372720-7CF528B9-9356-470B-A5EB-86C3DA769EC4Q33378422-9B2B49AE-C744-4871-85B7-ECC471CD0262Q33387153-7E7AD883-3042-47F9-82FB-C5F60112C915Q33390625-1E215E6A-A70C-48EA-9A9F-9D2A3044DA00Q33391229-B5E7940C-2A62-4FB4-9C00-06B6327FA83BQ33394636-A66C2F30-1179-4561-A1EA-0201EDA18712Q33394791-E3052A9E-0647-405B-8E02-336B10DEBCEDQ33394846-F5145256-5929-4237-ADFE-7A6C95494944Q33407279-1D372A04-4E40-46E2-8F85-A8F1033D147AQ33407802-375CE7E3-69D5-4934-B223-029C82729394Q33408850-B57D8CC1-B481-466B-8841-1F1E26025193Q33410668-F1376667-8999-44FD-A4FF-6A614DE6AAABQ33411387-7CA7AABA-F92A-42B2-8772-204FDD1F3414Q33413168-6336DB55-DCC0-4D6D-9A33-5563142A121DQ33413170-9BD3DDDA-E335-4DA9-B150-6ED7028596C1Q33413326-33B6F318-9829-4EA5-8179-98D75903637EQ33417700-57780CC5-C10B-42A3-9F21-FF52312234CBQ33418259-A007730D-7650-41B7-A06B-E9F25FDEC5CCQ33420059-D000C824-AED3-466B-A4A7-E067861B2E9EQ33420207-BA01C497-C6C1-4F59-95E0-2C98984D9CF7Q33425805-3EB03461-A7B8-4A2B-A153-3DDA11BE8BCFQ33435590-67775B26-46B6-45E4-B415-F1EDF3122AF5Q33440304-BD4E12E8-8D69-429F-A85E-6E12D5C1A291Q33441627-B29CC024-CA7F-4286-A662-904AA384D512Q33488235-1434BC57-900E-4F78-9A4E-2EC73FD6F59CQ33502827-F8FBD6FE-FDC7-4C0D-A053-286A8FA4B4E5Q33503064-FC9F61CE-E186-418E-97CD-E1215E409EED
P2860
The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production.
description
1994 nî lūn-bûn
@nan
1994 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
The purification of megapoieti ...... rowth and platelet production.
@ast
The purification of megapoieti ...... rowth and platelet production.
@en
type
label
The purification of megapoieti ...... rowth and platelet production.
@ast
The purification of megapoieti ...... rowth and platelet production.
@en
prefLabel
The purification of megapoieti ...... rowth and platelet production.
@ast
The purification of megapoieti ...... rowth and platelet production.
@en
P2093
P2860
P356
P1476
The purification of megapoieti ...... rowth and platelet production.
@en
P2093
D L Beeler
R D Rosenberg
P2860
P304
11104-11108
P356
10.1073/PNAS.91.23.11104
P407
P577
1994-11-01T00:00:00Z